NEMIS Technologies is a biotechnology company that develops diagnostic kits and solutions for accelerated microbiological.
Nemis Technologies has raised $3.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
Nemis Technologies's investors include Clave Capital, SICTIC.
Nemis Technologies is headquartered in Dubendorf, Switzerland.
NEMIS Technologies is a biotechnology company that develops diagnostic kits and solutions for accelerated microbiological.
Nemis Technologies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nemis Technologies — Funding & Investors." VCBacked, April 15, 2024, https://www.vcbacked.co/company/nemis-technologies. Accessed July 20, 2026.
VCBacked. (2024). Nemis Technologies — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/nemis-technologies
{{cite web |title=Nemis Technologies — Funding & Investors |url=https://www.vcbacked.co/company/nemis-technologies |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated